Skip to content

A study on drug prescription pattern in patients with dyslipidemia associated diabetes mellitus

Retrospective study on drug prescription pattern in patients with dyslipidemia associated diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037598
Enrollment
384
Registered
2021-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E085- Diabetes mellitus due to underlying condition with circulatory complications

Interventions

None listed

Sponsors

ABDUL SAFWAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: o All inpatients of either gender above 18 years diagnosed with dyslipidemia and type 2 diabetes mellitus admitted to general medicine department o A minimum of two drugs per prescription o Cost variation analysis for statins are included

Exclusion criteria

Exclusion criteria: o Patients referred to other department o Incomplete information record o Dyslipidemia drugs used for other diseases and treatments are excluded. o Cost variation for drug other than statins are excluded. o Combination regimen are excluded for cost variation analysis

Design outcomes

Primary

MeasureTime frame
Understanding prescription practices for dyslipidemia and diabetes mellitus Timepoint: Single point

Secondary

MeasureTime frame
Developing policies for appropriate use of drugs in complication of dyslipidemia in diabetic patients Timepoint: Single point

Countries

India

Contacts

Public ContactDr suresh G

NGSM Institute of Pharmaceutical Science NITTE(deemed to be university)

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026